News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Steve Kalivas

Advertisement

Articles by Steve Kalivas

It's not the hours, but how you spend them

BySteve Kalivas
May 1st 2001

Pharmaceutical Representative

Call preperation made easy.

Advertisement

Latest Updated Articles

  • It's not the hours, but how you spend them
    It's not the hours, but how you spend them

    May 1st 2001



Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments

2

Novo Nordisk Launches Multi-Month Subscription Program for Wegovy

3

Merck Enters $838 Million Research & Development Collaboration with Infinimmune

4

Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals

5

Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us